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Colorectal cancer, the third most common cancer globally, is a serious complication of 
inflammatory bowel disease (IBD), a chronic inflammatory disease of the intestine leading to 
colitis-associated colorectal cancer (CAC). Studies show that CAC can arise from a rare cell in 
the intestine called a tuft cell. DNA methylation changes that can affect gene expression have 
previously been detected in CAC. In this study, I will test the hypothesis that inhibition of DNA 
methylation inhibits CAC formation. This will be investigated using the tuft cell derived CAC 
mouse model. In this model, a genetic and a pharmacologic approach will be used to inhibit 
DNA methylation. I will then further investigate the mechanism by which inhibition of DNA 
methylation decreases tumor formation. This study will provide insight into the role of DNA 
methylation in tuft cells on CAC formation and shed light on whether modulating DNA 
methylation can affect CAC.  
 
